Marc Beer is a graduate of Miami University. He is highly recognized for development and commercialization expertise in diagnostics, device industries, biotechnology as well as pharmaceuticals for more than 25 years. He has been a CEO, chairman, and a co-founder in various companies. Some of the companies he helped found include Renovia. It was launched in 2016 together with the founding partners namely Ramon Iglesias and Yolanda Lorie and MD. The firm made an impressive close of Series A financing. It was a top healthcare venture capital funds.
Marc Beer joined Viacell and became its CEO in 2000. This is a biotechnology company that deals particularly with advancement, maintenance and accumulation of umbilical cord blood stem cells. The firm recorded great expansion with above 300 staff members under the entrepreneur’s leadership. Moreover, he is the founding chairman and chairman of several boards and committees. They include the Good Start Genetics Compensation committee. He is also a member of the Business Advisory Council and Minerva Neurosciences Inc. Audit committee.
The global leader is also the founding chairman of Renovia Company. Its mission is to discover and provide unique digital diagnostic and therapeutic devices. The target population is women with pelvic floor illnesses.
He was also a founding chairman at Minerva Neurosciences. This is a biopharmaceutical firm at a clinical stage. It is aimed at the development of a platform for product clients to alleviate disorders of the central nervous system. It is involved in developing innovative medicinal compounds for disorders such as insomnia and schizophrenia. Moreover, they conduct numerous late-stage clinical trials.
At the biopharmaceutical sector, he was tasked with addressing rare medical conditions on commercial launches. He worked in a biotechnology industry organization and was a member of mass life science in the Commonwealth Massachusetts board.
Most recently in 2019, the company LumeN XT selected Marc Beer to be chairman of the board. This is a privately-owned firm that specializes in the advancement of the proprietary surgical illumination product line. It is focused on minimally invasive surgeries. As a leader, he admits to being working with a team of professionals who have developed the field of surgical illumination. He acknowledges it as a safe procedure in surgery operation. Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html
As compared to traditional methods, targeted illumination technology is greatly improved. This is in terms of precision, visualization, and flexibility in the operations. LumeN XT provides a developed illumination platform that utilizes a mechanism with reduced heat. This enhances safety through improved visualization, disposable choices due to low costs, and better surgical precision.
Marc Beer has shown great endeavor in several start-up firms. He has offered guidance in the growth phases. This is owed to his broad experience in creating and launching organizations. In addition, he is renowned for directing new firms via the international commercial pathway of profitability.